CLONAZEPAM

Post-LOE

clonazepam

Teva

ANDAORALTABLET

Approved

Sep 1996

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

Schedule 4

CLONAZEPAM (clonazepam) by Teva. Approved for benzodiazepine [epc]. First approved in 1996.

Drug data last refreshed 19h ago

$0.0BPart D

Mechanism of Action

Pharmacologic Class:

Benzodiazepine

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (5)

NCT06834503Phase 4Not Yet Recruiting

Bioequivalence Study of Clonazepam 2 Mg Tablets

Started Jun 2025

24 enrolled

HealthyHealthy Donors

NCT03061136Phase 4Withdrawn

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

Started Oct 2016

SchizophreniaSchizoaffective DisorderSchizophreniform Disorder

NCT01932502Phase 4Unknown

Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy

Started Feb 2013

21 enrolled

Refractory Epilepsy

NCT00810316Phase 1Completed

Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population

Started Oct 2008

24 enrolled

Pharmacokinetics

NCT00594945Phase 2Completed

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Started Dec 2007

45 enrolled

Epilepsy

Worked on CLONAZEPAM at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.